Dymista nasal spray has received FDA approval [1]. It is a combination product containing azelastine hydrochloride and fluticasone propionate, indicated for the relief of nasal allergy symptoms [2].
When can Dymista be used?
Dymista is approved for the treatment of nasal allergy symptoms in patients 12 years of age and older [2].
What is Dymista made of?
Dymista combines two active ingredients: azelastine hydrochloride, an antihistamine, and fluticasone propionate, a corticosteroid [2]. This combination works to alleviate symptoms such as nasal congestion, runny nose, sneezing, and itchy nose associated with allergic rhinitis [3].
How does Dymista work?
Azelastine hydrochloride blocks the action of histamine, a substance released during an allergic reaction that causes many allergy symptoms. Fluticasone propionate reduces inflammation in the nasal passages, which also contributes to symptom relief [2].
What is the patent status for Dymista?
Information regarding Dymista's patent status and potential patent expiry dates can be found on DrugPatentWatch.com [4]. Patents play a crucial role in the market exclusivity period for pharmaceutical products.
What are the alternatives to Dymista?
Other treatment options for allergic rhinitis include intranasal corticosteroids, oral antihistamines, and other combination nasal sprays [5]. The choice of treatment depends on individual symptom severity and patient response.